PATENT CLAIM ANALYSIS

Application Number: 16037452
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "177000"]

Abstract:
Various pharmaceutical formulations are disclosed herein. For example, a pharmaceutical formulation is disclosed comprising ultra-micronized progesterone.

Claim (Index 6):
The pharmaceutical composition of  claim 1 , wherein the medium chain oil comprises at least one C6-C14 fatty acid mono-, di-, or tri-ester of glycerol or mono- or di-ester of a glycol.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 95.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14125547', '15454898', '13843428', '15090493', '14099598']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8190744978750988
- 35 USC 102 Novelty (BERT): 0.5827427865782973
- Combined Prediction Score: 0.7954413267454187
- Mean Citation Score: 426.441044
- Max Citation Score: 486.7579
- Similarity Product: 446.0317851384997

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test